Skip Navigation

Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug

Squawk on the Street

Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug

Novartis CEO Vas Narasimhan joins 'Squawk on the Street' to discuss the latest research that finds Kisqali - a breast cancer drug made by the company - lowers the risk of recurrence by 25%.

03:42

Fri, Jun 2 202312:21 PM EDT

This is going to be a choppy quarter, says 3Fourteen's Warren Pies

This is going to be a choppy quarter, says 3Fourteen's Warren Pies

The S&P 500 break doesn't mean it's time to be an uber bear, says RBC's Lori Calvasina

The S&P 500 break doesn't mean it's time to be an uber bear, says RBC's Lori Calvasina

Fed will keep rates higher longer: Ed Yardeni

Fed will keep rates higher longer: Ed Yardeni

UBS: The Fed will implement its first rate cut in September

UBS: The Fed will implement its first rate cut in September

Netflix will remain the global streaming leader, says TD Cowen's John Blackledge

Netflix will remain the global streaming leader, says TD Cowen's John Blackledge

This is going to be a choppy quarter, says 3Fourteen's Warren Pies

This is going to be a choppy quarter, says 3Fourteen's Warren Pies

The S&P 500 break doesn't mean it's time to be an uber bear, says RBC's Lori Calvasina

The S&P 500 break doesn't mean it's time to be an uber bear, says RBC's Lori Calvasina

Fed will keep rates higher longer: Ed Yardeni

Fed will keep rates higher longer: Ed Yardeni

UBS: The Fed will implement its first rate cut in September

UBS: The Fed will implement its first rate cut in September

Netflix will remain the global streaming leader, says TD Cowen's John Blackledge

Netflix will remain the global streaming leader, says TD Cowen's John Blackledge